GB0021055A
GB0021055D0
(en)
|
2000-08-26 |
2000-08-26 |
Method of treating metabolic disorders,espicially diabetes,or a disease or condition associated with diabetes
|
ARP000104821A
AR028299A1
(en)
|
1999-09-17 |
2000-09-14 |
A PHARMACEUTICAL COMPOSITION THAT INCLUDES NATEGLINIDA, A PROCESS FOR ITS PREPARATION AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETY.
|
CO00069666A
CO5200844A1
(en)
|
1999-09-17 |
2000-09-14 |
A COMBINATION THAT INCLUDES NATEGLINED AND WHEN AT LEAST ANOTHER ANTI-DIABETIC COMPOUND USED FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR OF A DISEASE OR CONDITION ASSOCIATED WITH DIBETES
|
NZ528738A
NZ528738A
(en)
|
1999-09-17 |
2000-09-15 |
Composition comprising nateglinide for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
AU79044/00A
AU7904400A
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
EP00969260A
EP1212077A2
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition of nateglinide and another antidiabetic agent
|
BR0014525-4A
BR0014525A
(en)
|
1999-09-17 |
2000-09-15 |
Process of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
PE2000000955A
PE20010739A1
(en)
|
1999-09-17 |
2000-09-15 |
COMBINATION OF NATEGLINIDE AND AN ANTIDIABETIC COMPOUND FOR THE TREATMENT OF METABOLIC DISORDERS, ESPECIALLY DIABETES, OR A DISEASE OR CONDITION ASSOCIATED WITH DIABETES
|
JP2001524585A
JP2003509457A
(en)
|
1999-09-17 |
2000-09-15 |
Methods for treating metabolic disorders, especially diabetes, or diabetes-related diseases or conditions
|
EP08167253A
EP2011507A2
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition of nateglinide and another antidiabetic agent
|
IL14816800A
IL148168A0
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition of nateglinide and another antidiabetic agent
|
KR1020047010952A
KR100544244B1
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
CNB008019762A
CN1309380C
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
CZ20011723A
CZ20011723A3
(en)
|
1999-09-17 |
2000-09-15 |
Combination containing nateglinide and pharmaceutical preparation in which this combination is comprised and which is intended for treating metabolic disorders, in particular diabetes and diseases and conditions associated therewith
|
MYPI20050152A
MY143051A
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
CN2007100789262A
CN101002758B
(en)
|
1999-09-17 |
2000-09-15 |
Use of composition for treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
TW092125226A
TWI278312B
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition for treating diabetes or a disease or condition associated with diabetes
|
KR10-2002-7003551A
KR100506428B1
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
FR0011782A
FR2798592B1
(en)
|
1999-09-17 |
2000-09-15 |
METHOD OF TREATING MATABOLIC DISORDERS, IN PARTICULAR DIABETES, OR DISEASE OR DISORDER ASSOCIATED WITH DIABETES
|
SG200401291A
SG127714A1
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especiallydiabetes, or a disease or condition associated wi th diabetes
|
MYPI20004314A
MY131810A
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
HU0400932A
HUP0400932A3
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
|
SK360-2002A
SK3602002A3
(en)
|
1999-09-17 |
2000-09-15 |
Combination containing nateglinide and pharmaceutical composition comprising said combination for treating metabolic disorders
|
BE2000/0585A
BE1013726A5
(en)
|
1999-09-17 |
2000-09-15 |
Method for the treatment of metabolic disorders, especially diabetes or disease or condition associated with diabetes.
|
TW089118960A
TWI278311B
(en)
|
1999-09-17 |
2000-09-15 |
Combination for treating diabetes or a disease or condition associated with diabetes
|
PL00354168A
PL354168A1
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition of nateglinide and another antidiabetcagent
|
NZ517280A
NZ517280A
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
PCT/EP2000/009074
WO2001021159A2
(en)
|
1999-09-17 |
2000-09-15 |
Pharmaceutical composition of nateglinide and another antidiabetcagent
|
CA2381992A
CA2381992C
(en)
|
1999-09-17 |
2000-09-15 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
ARP010100516A
AR028504A2
(en)
|
1999-09-17 |
2001-02-05 |
COMBINATION, METHOD FOR IMPROVING THE BODY APPEARANCE OF A MAMMER, PHARMACEUTICAL COMPOSITION, USE OF SUCH COMBINATION FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTION, DELAY OF PROGRESS, OR TREATMENT OF METABOLIC DISORDERS, AND COMMERCIAL PACKAGE
|
FI20010683A
FI20010683A
(en)
|
1999-09-17 |
2001-04-02 |
Procedure for the treatment of metabolic disorders, especially diabetes or a disease or condition associated with diabetes
|
NO20021197A
NO20021197L
(en)
|
1999-09-17 |
2002-03-11 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
HK02107767.4A
HK1046101A1
(en)
|
1999-09-17 |
2002-10-25 |
Pharmaceutical composition of nateglinide and another antidiabetic agent
|
US10/345,908
US6878749B2
(en)
|
1999-09-17 |
2003-01-16 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US11/036,842
US20050124663A1
(en)
|
1999-09-17 |
2005-01-14 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
JP2006241423A
JP2006335767A
(en)
|
1999-09-17 |
2006-09-06 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
US11/781,630
US20070275928A1
(en)
|
1999-09-17 |
2007-07-23 |
Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes
|
ARP090102868A
AR072329A2
(en)
|
1999-09-17 |
2009-07-28 |
PHARMACEUTICAL COMPOSITION THAT NATEGLINIDA UNDERSTANDS
|
US12/624,976
US20100076084A1
(en)
|
1999-09-17 |
2009-11-24 |
Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes
|